Avantor - AVTR Stock Forecast, Price & News

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Avantor Stock Up 0.9 %

Shares of NYSE:AVTR opened at $28.81 on Tuesday. The company has a debt-to-equity ratio of 1.41, a quick ratio of 1.05 and a current ratio of 1.64. The company has a market cap of $19.42 billion, a PE ratio of 30.98, a price-to-earnings-growth ratio of 0.70 and a beta of 1.30. Avantor has a 52 week low of $27.50 and a 52 week high of $44.37. The firm has a 50 day simple moving average of $30.22 and a 200 day simple moving average of $32.09.

Avantor (NYSE:AVTR - Get Rating) last released its earnings results on Thursday, July 28th. The company reported $0.37 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.38 by ($0.01). Avantor had a return on equity of 27.14% and a net margin of 8.27%. The company had revenue of $1.91 billion during the quarter, compared to analysts' expectations of $1.98 billion. During the same quarter in the previous year, the company earned $0.35 EPS. The firm's quarterly revenue was up 2.7% compared to the same quarter last year. As a group, research analysts expect that Avantor will post 1.46 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms recently weighed in on AVTR. Citigroup dropped their price objective on shares of Avantor from $38.00 to $32.00 and set a "neutral" rating on the stock in a research note on Monday, August 1st. Evercore ISI dropped their price objective on shares of Avantor to $35.00 in a research note on Tuesday, August 9th. Robert W. Baird dropped their price objective on shares of Avantor from $44.00 to $34.00 and set an "outperform" rating on the stock in a research note on Monday, August 1st. Barclays decreased their target price on shares of Avantor to $33.00 in a research report on Tuesday, August 9th. Finally, William Blair restated an "outperform" rating on shares of Avantor in a research report on Friday, April 29th. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Avantor presently has a consensus rating of "Moderate Buy" and a consensus target price of $39.00.

Insiders Place Their Bets

In other Avantor news, EVP Frederic Vanderhaegen sold 39,000 shares of the stock in a transaction that occurred on Monday, May 23rd. The shares were sold at an average price of $31.61, for a total value of $1,232,790.00. Following the completion of the sale, the executive vice president now owns 126,764 shares in the company, valued at approximately $4,007,010.04. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Avantor news, EVP Frederic Vanderhaegen sold 39,000 shares of the stock in a transaction that occurred on Monday, May 23rd. The shares were sold at an average price of $31.61, for a total value of $1,232,790.00. Following the completion of the sale, the executive vice president now owns 126,764 shares in the company, valued at approximately $4,007,010.04. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Gerard Brophy sold 19,603 shares of the firm's stock in a transaction on Friday, May 20th. The shares were sold at an average price of $31.27, for a total transaction of $612,985.81. Following the transaction, the executive vice president now owns 96,935 shares in the company, valued at approximately $3,031,157.45. The disclosure for this sale can be found here. Insiders own 1.60% of the company's stock.